Replies to post #10525 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

My problem is with their inability to close additional licenses. We will pop higher than this stock has ever risen. Anyone would be a fool to sell this stock when the future of this company would look brighter than ever. That is why it is so important to roll up their sleeves, make some concessions and just sign some agreements. The day we get FDA approval I would be at the doorstep of every Health Commissioner of every socialized country in the world.

[20cbocx]

This also my understanding. The testing done to adapt recaf to abt's equipment should have done in a clinical setting. The information required should be available but abt must submit it.